SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
IONIS PHARMACEUTICALS INC
@IONS_InsiderForm 4 Filing: LOSCALZO JOSEPH Acquires (Grant) shares of $IONS
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
IONIS PHARMACEUTICALS INC
Ticker: $IONS
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-01
Shares: 7,670
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, LOSCALZO JOSEPH, holds the title of Director at IONIS PHARMACEUTICALS INC.
On 2026-07-01, the insider transacted 7,670 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
LOSCALZO JOSEPH (Director) was granted $0 of $IONS
Post-Transaction Position: 5,369 shares
SEC Accession No: 0000874015-26-000231 (CIK: 1276128)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.